Kardiointerna s.r.o.
- Address
- Dolna 72, 974 01 Banská Bystrica, Slovakia
Kardiointerna s.r.o. - Cardiovascular and Metabolic Disease Research Center
Kardiointerna s.r.o. is a specialized clinical research center with extensive expertise in cardiovascular disease and metabolic disorders. The center focuses on evaluating innovative therapeutic approaches for complex cardiometabolic conditions, particularly in patients with multiple comorbidities requiring advanced treatment strategies.
- Heart failure management in patients with comorbid kidney impairment and cardiovascular risk reduction
- Severe hypertriglyceridemia treatment and lipid metabolism disorders
- Novel combination therapies and targeted RNA-based therapeutics for metabolic conditions
The research center demonstrates particular strength in conducting Phase III cardiovascular outcome trials, with a focus on evaluating combination drug therapies for heart failure patients with renal dysfunction. Additionally, Kardiointerna s.r.o. has established expertise in investigating emerging treatments for dyslipidemia, including advanced therapies targeting triglyceride reduction in both moderate and severe hypertriglyceridemia populations, reflecting their commitment to addressing critical unmet needs in cardiometabolic medicine.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Arrowhead Pharmaceuticals Inc.1active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Arrowhead Pharmaceuticals Inc.3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Kardiointerna s.r.o.
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Plozasiran in Adults with Severe Hypertriglyceridemia | Arrowhead Pharmaceuticals Inc. | Phase III | Not Recruiting | Oct 2024 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues | 3 | Unknown | 2024-10-31 | 2025-12-08 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.